🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Patients With Pancreatic Tumor: Use of an App to Monitor Progress in a Simple and Intuitive Way by Periodically Completing Targeted Questionnaires and Providing Educational and Informational Content (PancreasPlus).

RecruitingNAAges 18 Years - anyAllCasa di Cura Dott. Pederzoli
NCT07532590 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Caring for people with pancreatic cancer requires good coordination between hospital care and care at home, with different healthcare professionals working closely together. Patients are also becoming more involved in managing their own care on a daily basis. However, this active involvement can be difficult if there is poor communication with healthcare teams, differences in skills or familiarity with digital tools, or systems that do not support patient participation. The PancreasPlus app was developed to support patients and caregivers by providing reliable information, self-monitoring tools, and a communication channel with healthcare professionals. The study aims to assess the feasibility, patient engagement, and perceived quality of routine use of the app. It is hypothesized that its use will improve engagement, perceived quality, reduce anxiety and unplanned hospital visits, with

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥18; diagnosis of pancreatic cancer (histological/cytological) * Access to a smartphone or tablet and a data connection; basic digital literacy or a caregiver available, * Ability to understand and provide informed consent; understanding of the Italian language. Exclusion Criteria: * Severe uncompensated cognitive impairment, * Social or logistical circumstances that prevent follow-up or access to/use of the app, * Refusal or withdrawal of consent.
💊

What it tests

  • use of PancreasPlus app
📍

Where

2 sites
U.O. Chirurgia Generale 1, IRCCS San Matteo, Università degli Studi di Pavia
Pavia, Italy
Ospedale P. Pederzoli Casa di Cura Privata S.p.A.
Peschiera del Garda, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy